Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicine therapeutic approaches to overcome cancer drug resistance
Janet L. Markman, Arthur Rekechenetskiy, Eggehard Holler, et al.
Advanced Drug Delivery Reviews (2013) Vol. 65, Iss. 13-14, pp. 1866-1879
Open Access | Times Cited: 670

Showing 26-50 of 670 citing articles:

Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles
Hongxu Lu, Martina H. Stenzel
Small (2018) Vol. 14, Iss. 13
Closed Access | Times Cited: 203
Intracellular Self‐Assembly of Taxol Nanoparticles for Overcoming Multidrug Resistance
Yue Yuan, Lin Wang, Wei Du, et al.
Angewandte Chemie International Edition (2015) Vol. 54, Iss. 33, pp. 9700-9704
Open Access | Times Cited: 195
Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells
Paul N. Durfee, Yu‐Shen Lin, Darren R. Dunphy, et al.
ACS Nano (2016) Vol. 10, Iss. 9, pp. 8325-8345
Open Access | Times Cited: 195
Current developments and applications of microfluidic technology toward clinical translation of nanomedicines
Dongfei Liu, Hongbo Zhang, Flavia Fontana, et al.
Advanced Drug Delivery Reviews (2017) Vol. 128, pp. 54-83
Open Access | Times Cited: 194
Dynamically PEGylated and Borate‐Coordination‐Polymer‐Coated Polydopamine Nanoparticles for Synergetic Tumor‐Targeted, Chemo‐Photothermal Combination Therapy
Shucheng Liu, Jianming Pan, Jinxin Liu, et al.
Small (2018) Vol. 14, Iss. 13
Closed Access | Times Cited: 192
Application of polydopamine in tumor targeted drug delivery system and its drug release behavior
Zhe Wang, Yaou Duan, Yanwen Duan
Journal of Controlled Release (2018) Vol. 290, pp. 56-74
Closed Access | Times Cited: 192
Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
Giovanni Luca Beretta, Giuliana Cassinelli, Marzia Pennati, et al.
European Journal of Medicinal Chemistry (2017) Vol. 142, pp. 271-289
Closed Access | Times Cited: 189
Near-infrared-light responsive nanoscale drug delivery systems for cancer treatment
Guangbao Yang, Jingjing Liu, Yifan Wu, et al.
Coordination Chemistry Reviews (2016) Vol. 320-321, pp. 100-117
Closed Access | Times Cited: 182
Redox regulation in tumor cell epithelial–mesenchymal transition: molecular basis and therapeutic strategy
Jingwen Jiang, Kui Wang, Yan Chen, et al.
Signal Transduction and Targeted Therapy (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 182
Combination of nitric oxide and drug delivery systems: tools for overcoming drug resistance in chemotherapy
Jihoon Kim, Bryant C. Yung, Won Jong Kim, et al.
Journal of Controlled Release (2016) Vol. 263, pp. 223-230
Open Access | Times Cited: 176
Melanin‐Like Nanomaterials for Advanced Biomedical Applications: A Versatile Platform with Extraordinary Promise
Heng Liu, Youyuan Yang, Yu Liu, et al.
Advanced Science (2020) Vol. 7, Iss. 7
Open Access | Times Cited: 162
Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation
Wenxing Gu, Fenghua Meng, Rainer Haag, et al.
Journal of Controlled Release (2020) Vol. 329, pp. 676-695
Closed Access | Times Cited: 152
The Promise of Nanotechnology in Personalized Medicine
Maha Al‐Ghamdi, Antonino N. Fallica, Nicola Filippo Virzì, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 673-673
Open Access | Times Cited: 133
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Yanyan Xu, Jingyuan Xiong, Xiyang Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4327-4347
Open Access | Times Cited: 127
Understanding and targeting resistance mechanisms in cancer
Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 117
Advancement of metal compounds as therapeutic and diagnostic metallodrugs: Current frontiers and future perspectives
Imtiyaz Yousuf, Masrat Bashir, Farukh Arjmand, et al.
Coordination Chemistry Reviews (2021) Vol. 445, pp. 214104-214104
Closed Access | Times Cited: 112
Advances of medical nanorobots for future cancer treatments
Xiangyi Kong, Peng Gao, Jing Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 105
Nanomedicines and nanomaterials for cancer therapy: Progress, challenge and perspectives
Ziwei Jing, Qiuzheng Du, Xiaojian Zhang, et al.
Chemical Engineering Journal (2022) Vol. 446, pp. 137147-137147
Closed Access | Times Cited: 72
Deep Insight of Design, Mechanism, and Cancer Theranostic Strategy of Nanozymes
Lu Yang, Shuming Dong, Shili Gai, et al.
Nano-Micro Letters (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 68
Nanoparticle drug delivery systems for synergistic delivery of tumor therapy
Daoyuan Chen, Xuecun Liu, Xiaoyan Lu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 58
Mitochondria-associated ER stress evokes immunogenic cell death through the ROS-PERK-eIF2α pathway under PTT/CDT combined therapy
Xiaoli Feng, Tian Lin, Dong Chen, et al.
Acta Biomaterialia (2023) Vol. 160, pp. 211-224
Open Access | Times Cited: 56
Exploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine
Qi Wang, Keerthi Atluri, Amit K. Tiwari, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 433-433
Open Access | Times Cited: 51
The landscape of nanoparticle-based siRNA delivery and therapeutic development
Muhammad Moazzam, Jun Zhang, Abid Hussain, et al.
Molecular Therapy (2024) Vol. 32, Iss. 2, pp. 284-312
Closed Access | Times Cited: 50
A Journey of Challenges and Victories: A Bibliometric Worldview of Nanomedicine since the 21st Century
Jingyu Wang, Wenling Zhao, Zhao Zhang, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 39
Near‐Infrared Light‐Triggered MXene Nanocomposite for Tumor‐Specific Mild Photothermal‐Enhanced Chemodynamic Therapy
Peizheng Xiong, Xiaodan Wei, Li Zhou, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 44
Closed Access | Times Cited: 22

Scroll to top